Herbicide Manufacturer Settles Glyphosate Suits for $10B
The maker of Roundup has announced a settlement to pay over $10 billion to resolve approximately 95,000 claims linking the herbicide to cases of non-Hodgkin’s lymphoma, a form of cancer.
In a statement on June 24, the manufacturer agreed to settle the thousands of cases while continuing to sell the product without any additional warning on the label. The settlement also puts aside $1.25 billion for potential future claims for those who may yet develop non-Hodgkin’s lymphoma.
In June 2019, a California jury awarded a married couple more than $2 billion after lawyers successfully argued they were diagnosed with non-Hodgkin’s lymphoma after years of using Roundup. However, a California judge has since ruled the damages award is too high and now says the amount will likely be closer to $250 million.
EPA has done its own research on glyphosate. The Federal agency recently released a Proposed Interim Registration Review for glyphosate and found “no risk to public health when glyphosate is used in accordance with its current label and that glyphosate is not a carcinogen.”
While some dispute this finding, it is consistent with a 2017 EPA risk assessment for glyphosate and an Agricultural Health Study released last year.
Roundup is one of the most widely used herbicides in the world. Although early suites were brought forth by groundskeepers and homeowners, farmers make up the vast majority of Roundup’s sales. Farmers and agricultural associations argue the product is safe and more effective than alternatives when used correctly.
Check out the latest EPA compliance training options here:
Complete Environmental Regulations
Clean Air Act Regulations Online
TSCA Regulations Online
Clean Water Act & SDWA Regulations Online
Superfund and Right-to-Know Act Regulations Online
In a statement on June 24, the manufacturer agreed to settle the thousands of cases while continuing to sell the product without any additional warning on the label. The settlement also puts aside $1.25 billion for potential future claims for those who may yet develop non-Hodgkin’s lymphoma.
Glyphosate Embroiled in Controversy
The active ingredient, glyphosate, has been the center of the dispute, with some health experts claiming long-term use may increase the user’s risk of cancer.In June 2019, a California jury awarded a married couple more than $2 billion after lawyers successfully argued they were diagnosed with non-Hodgkin’s lymphoma after years of using Roundup. However, a California judge has since ruled the damages award is too high and now says the amount will likely be closer to $250 million.
EPA has done its own research on glyphosate. The Federal agency recently released a Proposed Interim Registration Review for glyphosate and found “no risk to public health when glyphosate is used in accordance with its current label and that glyphosate is not a carcinogen.”
While some dispute this finding, it is consistent with a 2017 EPA risk assessment for glyphosate and an Agricultural Health Study released last year.
Roundup is one of the most widely used herbicides in the world. Although early suites were brought forth by groundskeepers and homeowners, farmers make up the vast majority of Roundup’s sales. Farmers and agricultural associations argue the product is safe and more effective than alternatives when used correctly.
Convenient, Effective Online EHS Manager Training
Managing site compliance with the many complex EPA programs that affect your business—from the Clean Air and Clean Water Acts to TSCA, EPCRA, CERLCA, and more—is a major challenge. If you’re new to the field, or need an update on changing EPA rules, online training is a convenient way to quickly build in-depth expertise.Check out the latest EPA compliance training options here:
Complete Environmental Regulations
Clean Air Act Regulations Online
TSCA Regulations Online
Clean Water Act & SDWA Regulations Online
Superfund and Right-to-Know Act Regulations Online
Tags: environmental enforcement, FIFRA, glyphosate, herbicide, roundup
Find a Post
Recent Posts
Compliance Archives
Download Our Latest Whitepaper
Use this guide to help meet your OSH Act responsibilities to provide a safe, healthy workplace during a public health crisis.
By submitting your phone number, you agree to receive recurring marketing and training text messages. Consent to receive text messages is not required for any purchases. Text STOP at any time to cancel. Message and data rates may apply. View our Terms & Conditions and Privacy Policy.